08:46 AM EDT, 11/01/2024 (MT Newswires) -- Sutro Biopharma ( STRO ) said Friday it has opened enrollment for its registration-directed study of the drug luveltamab tazevibulin in children with a certain type of acute myeloid leukemia.
The trial is global and the majority of the sites are planned to be open by the end of the year, the company said.